April 20, 2012
The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), based in Kumamoto City, and Astellas Pharma on April 19 announced that they entered into an agreement on the previous day for the sales and marketing of Kaketsuken’s precipitated, purified diphtheria-pertussis-tetanus inactivated polio (derived from...read more